Headquartered in Dublin, ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development.
Commenting on the completion of the acquisition, ICON Chief Executive Officer, Ciaran Murray, said: “Helping customers establish and communicate the value of their products has become increasingly important as payers look for evidence linking efficacy, value and price. MediMedia deepens the expertise and capabilities of our market-leading commercialization and outcomes group and brings outstanding scientific and medical communications capabilities. We are delighted to welcome them to the ICON team.”
MediMedia Managed Markets is a leading provider of strategic payer-validated market access solutions for the biopharmaceutical and medical device industries. This acquisition extends ICON’s leadership in commercialization and market access services and brings new scientific communications capabilities which together with ICON’s existing Commercialization and Outcomes practices,